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Abstract
Background: The adoption of the electronic medical record (EMR) is rapidly growing in China. Constantly evolving,
Chinese EMRs contain vast amounts of clinical and financial data, providing tremendous potential for research and
policy use; however, they are only partially standardized and contain free text or unstructured data. To utilize the
information contained in Chinese EMRs, the development of data extraction methodology is urgently needed. The
purpose of this study is to develop and validate methods to extract clinical information from the Chinese EMR for
research use.
Methods: Using 2010 to 2014 EMR data from YouAn Hospital, a large teaching hospital affiliated with Capital
Medical University in Beijing, China, we developed extraction methods including 40 EMR definitions for defining
6 liver disease, 5 disease severity conditions, and 29 comorbidities and treatments. We conducted a chart review
of 450 randomly selected EMRs. Using physician chart review results as a reference, sensitivity, specificity, positive
predictive value (PPV), and negative predictive value (NPV) were calculated to validate each EMR definition.
Results: The sensitivity of the 6 EMR definitions for liver diseases ranged from 78.9 to 100.0 %, and PPV ranged
from 82.1 to 100.0 %. The sensitivity of the 5 definitions on disease severity conditions ranged from 91.0 to 100.
0 %, and PPV ranged from 79.2 to 100.0 %. Among the 29 EMR definitions for comorbidities and treatments, 23
had sensitivity over 90.0 % and 25 had PPV over 80.0 %. The specificity and NPV for all 40 EMR definitions were
over 90.0 %.
Conclusion: The extraction method developed is a valid way of extracting information on liver diseases,
comorbidities and related treatments from YouAn hospital EMRs. Our method should be modified for
application to other Chinese EMR systems, following our framework for extracting conditions.
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Background
Epidemiological and clinical outcome studies of liver
diseases require large databases and rich case mix infor-
mation to incorporate severity assessment and risk ad-
justment in order to generate robust results [1]. Many
researchers in China are currently seeking to explore
liver disease using clinical data, given that China has a
high prevalence of liver diseases. Chronic hepatitis is the
major cause of primary liver cancer (PLC) in the Chinese
population. In China, the prevalence of hepatitis B virus
infection is 7.2 %, and an estimated 20 million people
suffer from chronic hepatitis B [2, 3]. The high preva-
lence of chronic hepatitis has resulted in a high inci-
dence of PLC: an estimated 360,000 new cases of PLC
occur in China each year [4].
The implementation of the electronic medical record
(EMR) in China has been rapidly growing since 2006 [5].
Developing the EMR has been identified as a primary
focus for China’s new and on-going health care reforms
[6]. Currently, most hospitals in China use EMR systems.
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The coverage, functionality, and interoperability of the
EMR will continue to be greatly improved as these devel-
opments take place. In addition to the advantages of the
EMR including large geographical coverage and easy ac-
cess, they also hold tremendous potential to provide rich
and timely longitudinal clinical data for research [5, 7].
Researchers worldwide have recognized the potential
value of EMRs and tremendous efforts are underway to
advance research in EMR data science [8–10].
The utility of Chinese EMRs for research, however,
must take into account the specific features of the EMR
systems. Similarly with other countries, EMR systems in
China contain longitudinal and comprehensive docu-
mentation of clinical care and management of patients’
hospitalizations. Information on diagnoses, laboratory
tests, radiology examinations, hospital costs, procedure
reports, and prescriptions is recorded. EMR data is in-
putted by physicians and regularly audited by hospital
medical record departments, as the quality of the EMR
is part of the physicians’ monthly performance evalua-
tions. In spite of national standards to improve interoper-
ability, however, EMR systems in China are only partially
standardized [5–7]. This is because each hospital in China
chooses its own vendor to develop an EMR system, with
different vendors having developed different systems.
These EMR systems incorporate many free-text fields
with unstructured data; structured drop-down lists
are limited to the documentation of demographics,
physical examinations, and drug prescriptions. Add-
itionally, the standardized coding system, such as the
International Classification of Diseases (ICD), is not
used to document clinical conditions in Chinese
EMRs [5–7].
In recent years, methodologies that extract informa-
tion from EMRs have been improved. One outstanding
example is the electronic phenotyping algorithms that
were developed by the electronic medical records and
genomics (eMERGE) network [11, 12]. These algorithms
require the ICD codes and Current Procedural Termin-
ology (CPT) to be present in EMR data [11, 13]. How-
ever, in addition to language differences (i.e., English
versus Chinese), the lack of standardized coding systems
(e.g., ICD) in Chinese EMRs makes existing extraction
methods, such as the eMERGE phenotyping algorithms,
inapplicable to Chinese EMRs. Another barrier for using
Chinese EMRs to define disease conditions is the lack of
validated tools for dealing with unstructured free-text.
Natural Language Processing (NLP) is a sophisticated
tool that is used to convert unstructured free-text into
structured data. However, well-established and widely
validated NLP techniques for dealing with Chinese
EMRs are not currently available. Studies of NLP for
Chinese EMRs are limited, with most having been devel-
oped for one or several specific sections or fields of the
EMR [14–16]. Additionally, clinical expertise is needed
to define conditions (such as liver diseases, symptoms
and comorbidities) according to practice pathways be-
cause the EMRs in China document longitudinal clinical
information on patients, but do not document diagnoses
in a standardized or systematic way. For example, a
patient’s illness history, biomarker level, and imaging re-
ports represent some of the information that is captured
in EMRs and can be combined to define PLC.
In order to leverage the use of existing Chinese EMRs,
there is a need to develop new data extraction methods
that incorporate clinical expertise and make use of free-
text and non-standardized coded data to accurately de-
fine conditions. In this study, we aimed to develop and
validate extraction methods to define disease conditions
in Chinese EMRs, specifically focusing on liver diseases,
which are widely used in liver disease outcome and risk
adjustment studies. Our methodology also provides a
framework for constructing and defining other condi-
tions in Chinese EMRs.
Methods
Data source
The EMR data was collected and extracted from the
EMR system at YouAn hospital, which is affiliated with
Capital Medical University in Beijing, China. YouAn is
one of the leading teaching hospitals in China. It special-
izes in delivering care to patients with liver diseases, and
treats over 300,000 patients annually from all regions of
China. The EMR system in use at YouAn hospital was
developed using Structured Query Language (SQL), a
method that is widely used across other Chinese EMR
systems. For each patient, the EMR contains several sec-
tions, including a front page (completed after discharge)
that summarizes the hospitalization, as well as an admis-
sion record, discharge record, surgery/procedure record,
death record, laboratory test results, radiology test re-
sults, pathology reports, physician notes, hospitalization
cost records, and electronic drug prescriptions (see Fig. 1,
which illustrates the main structure of this EMR). The
sections for laboratory test results, electronic prescrip-
tions, and hospitalization cost records are entirely struc-
tured, without any free text. However, the front page,
admission record, discharge record, and radiology test
results are only semi-structured and contain both struc-
tured drop-down lists and free-text fields. YouAn assigns
a unique identification number to each patient, which
allows for the linkage of multiple EMR sections.
For this study, we included patients who were admit-
ted to YouAn hospital between January 1, 2010 and
August 15, 2014. This resulted in a sample of 85,524
EMRs. All the included patients consented to having
their EMRs used for scientific research, as the consent
form was integrated directly into the EMR. It is
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estimated that over 95 % of patients admitted to YouAn
hospital have agreed and signed this consent form.
EMR extraction method
We developed 40 EMR definitions for 6 liver diseases, 5
disease severity conditions and 29 comorbidities and
treatments (Additional file 1: Table S1, which shows a
list of EMR definitions for liver diseases, disease severity
conditions, comorbidities and treatments developed in
this study). We queried the EMR data using the SQL
system. There were three steps in the development of
each EMR definition. First, we developed the keywords
that were corresponding to different free-text entries of
the EMR. Keywords included Chinese words and punc-
tuation, and were combined using “AND”/“OR” opera-
tors. Because there are various ways of indicating a
clinical condition in free text in Chinese, we attempted
to include all potential disease descriptions and specific
terms in a group of search terms that are specific to each
condition based on our knowledge of physician docu-
mentation style for a specific disease and the guidelines
or rules for documenting clinical information in a par-
ticular EMR section. Second, we selected corresponding
sections and fields in the EMR for searching the key-
words, such as the 40 diagnosis fields in the admission
record, conclusive sentences in pathology or radiology
reports, and laboratory results. We determined the areas
of focus by considering the disease diagnostic pathway,
as well as the availability, completeness, and temporality
of information in the EMR. The third step consisted of
logically combining the search results from selected
fields. Our logical combination embedded the inclusion
and exclusion criteria in light of clinical expertise. We
defined the liver diseases using national and inter-
national practice guidelines [17–21]. An example of our
extraction method for PLC is illustrated in Fig. 1. Finally,
we tested the EMR definitions on a 10 % sample of the
reviewed EMRs (45 EMRs) to include comprehensive
Fig. 1 The main structure of Chinese EMR and extraction method for Primary Liver Cancer (PLC)
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lists of the keywords and detect and fix errors, such as
inadequate inclusion of search fields, misspelling, wrong
search sections, and errors in SQL syntax and clinic
logics. Through an iterative process of testing and revis-
ing, we finalized the 40 EMR definition algorithms
(available at: http://themethodshub/toolbox/downloads).
In our method, the common liver diseases extracted
from the EMR included: PLC, hepatitis B, hepatitis C,
fatty liver, alcoholic liver diseases and cirrhosis. In
addition, the following disease severity conditions were
also extracted: hepatic encephalopathy, spontaneous bac-
terial peritonitis, variceal hemorrhage, hepatorenal syn-
drome, and ascites. Along with other laboratory test
results (i.e., prothrombin time and serous level of albu-
min, creatinine, sodium and total bilirubin), these vari-
ables can be used to calculate a Child-Pugh score [22],
model for end-stage liver disease (MELD) index [23],
MELD-Sodium index (MELD-Na) [24] and five-variable
MELD (5vMELD) index [24]. These indexes are widely
used to assess the severity of liver disease in clinical set-
tings. For the purpose of risk adjustment, we extracted
the comorbidities included in the Charlson Comorbidity
Index (CCI) [25] and Elixhauser Comorbidity Index
(ECI) [26], which are commonly used risk adjustors. We
extracted treatment or procedure measures, which are
highly recommended for consideration in outcome and
risk adjustment studies [27].
EMR review
Using patients’ unique identification number, we ran-
domly selected 450 patients and extracted their EMRs
(450 EMRs) from the entire 85,524 EMRs. To validate
the EMR definitions, two hepatologists who were
blinded to the EMR definitions reviewed the EMRs. For
training purposes, each physician first reviewed the same
20 EMRs independently. Study team members ensured
the accuracy and consistency of the EMR review process
by comparing physician review results. Inconsistencies
or uncertainties in decisions were brought to the team
for discussion. Each physician then reviewed 250 full
EMRs, of which 50 EMRs were independently reviewed
by both reviewers to assess the inter-rater agreement.
Kappa-statistic (K-statistic) was calculated to assess
inter-rater agreement between physician reviewers. Of
the 40 EMR definitions, we were able to calculate a k
statistic for 32 definitions. Of the 32 definitions, 30
definitions had a k-statistic between 0.4 and 1.0, and 2
definitions were between 0.2 and 0.4. It was not possible
to calculate a k-statistic for the remaining 8 definitions,
given that there were “0” cells in the contingency tables
due to the low prevalence of some conditions. In this
case, the observed agreement was used to evaluate the
agreement (over 85.0 %).
Statistical analysis
Descriptive statistics were calculated for demographic
characteristics, liver diseases, disease severity condi-
tions, and comorbidities. Sensitivity, specificity, posi-
tive predictive value (PPV), and negative predictive
value (NPV) and its 95 % confidence intervals of the
EMR definitions were assessed based on the reference
of EMR review results.
We tried several different EMR definitions for each in-
dividual disease, symptom or treatment. Three types of
EMR definitions were constructed: 1) definition based
on diagnosis information (admission and discharge)
only; 2) definition based on supporting clinical evidence
only, such as the information from the laboratory test
results, imaging results, pathologic reports, illness his-
tory, procedure records and prescription; and, 3) defin-
ition based on both diagnosis and supporting clinical
evidence. For each disease, symptom or treatment, after
comparing the validity of different EMR definitions, the
one with highest validity was chosen.
All statistical analyses were performed using SAS v.
9.4 (SAS Institute, Cary, NC) and Stata v. 12.0 (Stata-
Corp, College Station, TX).
Results
Among the 450 randomly selected patients whose re-
cords were reviewed for validation, 234 (52.0 %) were
male and 328 (72.9 %) were between 18 and 64 years old
(Table 1). The prevalence of liver diseases in the sample
was 21.3 % for PLC, 32.7 % for cirrhosis, 45.1 % for
hepatitis B, 8.9 % for hepatitis C, 7.1 % for alcoholic liver
disease, and 4.0 % for fatty liver. Of the sample, 68.9 %
had at least one of the comorbidities included in CCI
and 71.8 % had at least one of the comorbidities in-
cluded in ECI.
We validated 40 EMR definitions, which were classi-
fied into three groups: 6 definitions for liver diseases, 5
definitions for severity of liver disease, and 29 definitions
for comorbidities and treatments. The validity of 11
EMR definitions for liver diseases and disease severity
conditions is shown in Table 2. For the 6 definitions for
liver diseases (i.e., PLC, hepatitis B, hepatitis C, cirrho-
sis, fatty liver, and alcoholic liver diseases), the sensi-
tivity ranged from 78.9 to 100.0 %, and PPV ranged
from 82.1 to 100.0 %. The sensitivity of 5 definitions
for the severity of liver disease (i.e., HE, ascites, SBP,
VH and HR) ranged from 91.0 to 100.0 % (see Table 2).
The specificity and NPV for all 40 EMR definitions
were over 90.0 %.
The summary of the validity for the additional 29
EMR definitions is shown in Table 3 (for detailed validity
results of these 29 EMR definitions for comorbidities
and treatments see Additional file 1: Table S2). The sen-
sitivity of the 29 EMR definitions ranged from 64.7 to
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100.0 %; 23 definitions had sensitivity over 90 %. The
PPV of the 29 EMR definitions ranged from 64.1 to
100 %; 25 definitions had a PPV of over 80.0 %.
Discussion
The current rapid development of EMRs in China pre-
sents great potential for health researchers and policy
makers. However, significant challenges remain on how
to make use of the information present in Chinese
EMRs, as their special features make the application of
existing data extraction methods infeasible. In this
study, we developed an EMR data extraction method
including 40 EMR definitions for liver diseases, liver
disease severity conditions, comorbidities and treat-
ments using Chinese EMRs. The validity of the EMR
definitions developed in this study was overall shown to
be high, with some variations across definitions. Most
of the EMR definitions had over 80.0 % sensitivity (33
out of 40 variables), 90.0 % specificity (all 40 variables),
80.0 % PPV (35 out of 40 variables), and 90.0 % NPV
(all 40 variables).
Table 2 Validity of EMRa definitions for liver disease
Variable Sensitivity % (95 % CIb) Specificity % (95 % CI) PPVc % (95 % CI) NPVd % (95 % CI)
Liver disease
Primary liver cancer 100.0 (96.2, 100.0) 98.9 (97.1, 99.7) 96.0 (90.1, 98.9) 100.0 (99.0, 100.0)
Hepatitis B 88.2 (82.9, 92.3) 98.8 (96.5, 99.8) 98.4 (95.3, 99.7) 91.0 (87.0, 94.2)
Hepatitis C 82.5 (67.2, 92.7) 99.5 (98.3, 99.9) 94.3 (80.8, 99.3) 98.3 (96.6, 99.3)
Fatty liver 100.0 (81.5, 100.0) 100.0 (99.2, 100.0) 100.0 (81.5, 100.0) 100.0 (99.2, 100.0)
Alcoholic liver disease 100.0 (89.1, 100.0) 98.3 (96.6, 99.3) 82.1 (66.5, 92.5) 100.0 (99.1, 100.0)
Cirrhosis 78.9 (71.4, 85.2) 98.4 (96.2, 99.5) 95.9 (90.6, 98.6) 90.6 (86.9, 93.5)
Liver disease severity
Spontaneous bacterial peritonitis 91.0 (81.5, 96.6) 99.7 (98.6, 100.0) 98.4 (91.3, 100.0) 98.5 (96.7, 99.4)
Variceal hemorrhage 95.0 (75.1, 99.9) 98.8 (97.3, 99.6) 79.2 (57.9, 92.9) 99.8 (98.7, 100.0)
Hepatorenal syndrome 100.0 (47.8, 100.0) 100.0 (99.2, 100.0) 100.0 (47.8, 100.0) 100.0 (99.2, 100.0)
Hepatic encephalopathy 100.0 (91.2, 100.0) 100.0 (99.1, 100.0) 100.0 (91.2, 100.0) 100.0 (99.1, 100.0)
Ascites 95.2 (89.8, 98.2) 99.1 (97.3, 99.8) 97.5 (92.9, 99.5) 98.2 (96.1, 99.3)
aEMR electronic medical records; bCI confidence interval; cPPV positive predictive value; dNPV negative predictive value
Table 3 Number and percent of EMRa definitions for comorbidities
or treatments by validity range out of 29 EMR definitions
Range Sensitivity Specificity PPVb NPVc
60.0 % - 69.9 % 3 (10.3 %) 0 2 (6.9 %) 0
70.0 % - 79.9 % 3 (10.3 %) 0 2 (6.9 %) 0
80.0 % - 89.9 % 0 0 5 (17.2 %) 0
≥90.0 % 23 (79.3 %) 29 (100 %) 20 (69.0 %) 29 (100 %)
aEMR electronic medical record; bPPV positive predictive value; cNPV negative
predictive value
Table 1 Patient’s Characteristics (N = 450)






Primary liver cancer 21.3 (96)
Cirrhosis 32.7 (147)
Hepatitis B 45.1 (203)
Hepatitis C 8.9 (40)
Fatty liver 4.0 (18)
Alcoholic liver disease 7.1 (32)
Spontaneous bacterial peritonitis 14.9 (67)
Variceal hemorrhage 4.4 (20)
Hepatorenal syndrome 1.1 (5)
Hepatic encephalopathy 8.9 (40)
Ascites 27.6 (124)




3 and more 12.9 (58)




3 and more 32.2 (145)
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Validity of the EMR definitions and comparison with
other studies
We did not find any other studies that used methods
comparable to ours, however to assess the level of valid-
ity in our study, we referenced several relevant previous
studies. Compared with the case definition of hepatocel-
lular carcinoma (HCC) using pathologic reports and ad-
ministrative data in the United States [8], our EMR
definition for PLC (mainly consists of HCC) had a
slightly higher validity with a sensitivity of 100.0 % ver-
sus 96.0 %, and a specificity of 98.9 % versus 97.0 %.
One study that validated ICD administrative data at the
University of Pennsylvania Health System [28] found a
lower PPV than ours for hepatitis C (88.0 % versus
94.3 %) and hepatitis B (81.3 % versus 98.4 %). Our EMR
definitions for comorbidities such as hypertension,
diabetes, chronic obstructive pulmonary disease, and
depression also had higher validity than another study
that used Canadian primary healthcare EMRs [9]. In
addition, the EMR definition for acquired immune defi-
ciency syndrome (AIDS) also reported very high validity,
similar to the findings of another study [29]. The high
validity of our definitions is likely related to the high
quality of physician documentation, as well as the struc-
ture of Chinese EMRs. In China, there are specific cri-
teria/rules for physicians to follow when documenting
clinical information using EMRs (e.g., one diagnosis field
assigned for each diagnosis). The EMRs are also fully
structured for reporting laboratory tests (i.e., serous level
of albumin, creatinine, sodium and total bilirubin, and
prothrombin time).
Our EMR definitions achieved PPV results similar to
those of the eMERGE phenotype algorithms. Among
different sites of eMERGE, PPV ranged from 98.2 to
100.0 % for diabetes, 84.0 to 100.0 % for hypertension,
73.0 to 84.0 % for dementia, and 92.0 to 96.0 % for
chronic kidney disease [30]. An EMR definition of myo-
cardial infarction using the United Kingdom’s elec-
tronic clinical data [31] had a higher PPV than ours
(85.3 % versus 66.7 %). Given the fact that PPV is
prevalence sensitive, the lower PPV of the myocardial
infarction definition in our study might be partially ex-
plained by the low prevalence (0.44 %) of this condition
in our data set.
Notably, the validity of the developed EMR definitions
varied by extracted diseases/treatments, with low sensi-
tivity for cirrhosis (78.9 %), fluid and electrolyte disor-
ders (65.4 %), valvular disease (66.7 %), metastatic solid
tumor (72.7 %) and peptic ulcer disease (64.7 %). There
are several possible explanations. First, the diagnoses of
these conditions are complex and/or contain a wide
range of sub-diagnoses, such as metastatic solid tumor
and peptic ulcer disease, which requires the integration
of clinical evidence and physician judgment. Second,
disease-related information is not always well docu-
mented in EMRs (e.g., a pathology report is only avail-
able for patient who underwent tissue biopsy or
surgery). Third, some minor diseases, such as fluid and
electrolyte disorders, have a relatively short recovery
time, and physicians may not document the diagnosis
during hospitalization.
Our results indicated that the validity of some EMR
definitions only slightly improved after adding laboratory
test results or prescription information. For example,
after adding prescription information into the EMR
definition for hepatitis B, which previously only con-
tained diagnosis information, sensitivity improved
slightly from 86.8 to 88.2 % and PPV improved from
97.8 to 98.4 %. We found similar results for hepatic
encephalopathy and AIDS. This indicates that the
diagnoses in EMRs may be sensitive enough for devel-
oping case definitions for conditions, such as hepatitis
B, hepatic encephalopathy, and AIDS.
Application of the developed extraction method
The developed EMR definition consists of three compo-
nents: Chinese language search terms, targeted fields to
search, and the logical connection of the extracted infor-
mation. The search terms can be used directly in other
EMRs, given that we developed them based on the phys-
ician documentation style used for a specific disease.
Although the specific details of EMR systems vary across
hospitals in China, the high-level structure and data
fields used in this study remain similar under national
EMR standards [6]. Chinese EMR systems contain all
necessary and essential sections or fields facilitating the
application of our extraction method. The third compo-
nent was developed based on the clinical practice path-
way or diagnostic guidelines for each disease. However,
our extracting method should be modified to fit unique
Chinese EMR systems. For extracting variables not in-
cluded in this study, the framework for constructing the
extraction method includes: 1) determining the search
fields; in most scenarios, EMRs include diagnoses in ad-
mission or discharge records, conclusive sentences in
pathology or imaging reports, and corresponding labora-
tory test results; 2) developing keywords for searching
the fields that are specific to the disease, based on the
clinical expertise and documentation styles used by phy-
sicians; and 3) combining the search results based on
the specific diagnostic guidelines.
Our extraction method utilized the free-text within
the Chinese EMR, which contains rich clinical informa-
tion and accounts for a large part of the EMR. In exist-
ing EMR extraction methods, NLP is commonly used to
work with free text. We did not use NLP because well-
established and widely validated NLP for dealing with
various Chinese EMRs is currently not available. Instead,
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our extracting method searched for documented key-
words. This technique was practical and feasible because
not only do certain sections of the Chinese EMR with
free text data entries consist of one conclusive sentence
or several words, our methods also searched a small
number of the most relevant free-text entries (diagnoses
and conclusive sentences). Generally, in Chinese EMRs,
these free-text entry fields are generic in terms of what
diagnosis or other information can be entered, therefore
the variation in how these fields are recorded by physi-
cians is limited, as physicians are required to follow
standardized criteria when inputting diagnoses or
conclusive sentences in these fields. This enhances the
potential of our methodology to be applied to other
Chinese EMRs.
EMRs serve as a tool to facilitate medical documenta-
tion in the clinical setting, and also provide rich data to
contribute to evidence-based medicine. The new meth-
odology proposed in this study for extracting informa-
tion from the Chinese EMRs could transfer rich EMR
data into a ready-for-analysis format, and provide timely
information for prognosis prediction, risk adjustment,
and quality assessment. Our methods will enable and
leverage clinical and epidemiological applied studies to
use EMR data for generating knowledge for evidence-
based medical practice.
Challenges and limitations
We faced challenges common to the development of all
EMR data extraction methods. This included how to
best handle the combination of information derived
from different parts of the EMR, and the temporality of
information, for instance blood test results, missing
values, and free text components.
Our study has several limitations. First, we used an
EMR physician review as our gold standard, although
the validity of reviewed EMRs is unknown. However, it
is widely agreed upon that performing a medical record
review is an adequate standard for use in validation
studies [32]. This may be especially true for Chinese
hospitals in which EMRs are routinely audited by med-
ical record departments. The quality of the documenta-
tion is considered an indicator of physician performance
in monthly evaluations. Second, aside from the reported
40 EMR definitions, we developed an additional 10 EMR
definitions for other liver diseases and comorbidities
(i.e., intrahepatic cholangiocarcinoma, pulmonary circu-
lation disorders, paralysis, lymphoma, coagulopathy,
psychoses, congestive heart failure, peripheral vascular
disease, weight loss and dementia) (see Additional file 1:
Table S1). However, we were unable to assess the validity
of these conditions due to low prevalence. Third, we
developed and validated EMR definitions in one hospital
that specializes in diagnosing and treating liver disease
and therefore the statistics of validity were influenced by
disease prevalence in our sample. To apply our
methods, users should modify our data extraction
methodology to fit their EMR systems and further val-
idate this in their EMRs.
Conclusion
The developed EMR definitions presented in this study
had high validity. Our method should be modified for
application to other Chinese EMR systems, following
our framework for extracting conditions. Our method
contributes to current efforts that attempt to make use
of the robust clinical data sources in China to leverage
outcome researches. Future research should focus on
testing our extraction method in other EMR data and
modifying it for use with other conditions. This will in
turn provide informative, timely and interoperable clin-
ical data for researchers and policy makers.
Additional file
Additional file 1: Table S1. EMR definitions for liver diseases, disease
severity conditions, comorbidities and treatments. Table S2. Validity results
of the 29 EMR definitions for comorbidities and treatments. (DOC 251 kb)
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